The purpose of this study is to obtain data on the performance of the EC-3 lens at an interval of two years (and beyond) from subjects who were implanted. The primary aim of the study will be to evaluate the presence, if any, of PCO, lens glistening, and other anomalies in the subjects.
Anomalies include, but are not limited to: Posterior Capsule Opacification (PCO) (pathological condition) - delayed clouding of the lens capsule after cataract surgery. Glistenings - fluid-filled micro-vacuoles that form within the intraocular lens (IOL) optic when the IOL is in an aqueous environment. They may appear to be on the lens surface. Artifacts - glares, halos, starbursts and/or shadows caused by IOLs. Fibrosis - the formation of fibrous connective tissue, as in a scar. Glare - undesirable sensation produced by brightness that is much greater than that to which the eyes are adapted. Causes annoyance, discomfort, or loss in visual performance. Halos (symptom) - the appearance of hazy ring(s) around light.
Study Type
OBSERVATIONAL
Enrollment
100
Stephenson Eye Associates
Venice, Florida, United States
Eyesight Ophthalmic Services
Dover, New Hampshire, United States
Cabinet d'Ophtalmologie du Dr. Pey
Le Puy-en-Velay, France
To evaluate the presence, if any, of PCO (Posterior Capsule Opacification) in the EC-3 lens.
Routine eye exam by the investigator.
Time frame: 2-3 years post-implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.